An optimized and validated 384-well plate assay to test platelet function in a high-throughput screening format

The spatial molecular pattern of integrin recognition sites and their immobilization to colloidal nanobeads determine α2β1 integrin-dependent platelet activation

(2018) Augusto Martins Lima et al.   BIOMATERIALS

Current and future antiplatelet therapies: emphasis on preserving haemostasis

(2018) James D. McFadyen et al.   Nature Reviews Cardiology

Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes

(2015) D. Nicholas Bateman et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing

(2014) Lewis Taylor et al.   PLoS One

Synthesis of Indole Derived Protease-Activated Receptor 4 Antagonists and Characterization in Human Platelets

(2013) Summer E. Young et al.   PLoS One

State of the Art in Platelet Function Testing

(2013) Beate E. Kehrel et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor

(2012) Chris Dockendorff et al.   ACS Medicinal Chemistry Letters

Principles of early drug discovery

(2010) JP Hughes et al.   BRITISH JOURNAL OF PHARMACOLOGY

Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods

(2009) N. J. TRUSS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS